Oztürk Bülent, Cetinkaya Mesut, Oztekin Volkan, Inal Gürdal, Adsan Oztuğ, Uğurlu Ozgür, Ozden Cüneyt
2nd Urology Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey.
Urol Int. 2003;71(1):22-5. doi: 10.1159/000071088.
We studied the impact of diuresis forced by oral hydration or single-dose oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms.
A total of 58 patients with a mean age of 59 (range 41-77) years who presented with lower urinary tract symptoms were included in the study. The patients were grouped with respect to their International Prostate Symptom Scores as having mild, moderate, or severe symptoms. The prostatic volumes of the patients were calculated using transrectal ultrasound. Uroflowmetric measurements were performed on 3 consecutive days. On the 1st day, the test was performed without diuretic stimulation; on the 2nd day, oral hydration was applied, and on the 3rd day, the patients received 20 mg of furosemide orally. Voiding time, maximum flow rate, voided volume, and the time elapsed in minutes until voiding (waiting time) were recorded.
Diuretic stimulation did not significantly alter the uroflowmetric parameters in each symptom group, but the waiting time was significantly reduced. Forced diuresis caused acute urinary retention in 5 of 20 (25%) severely symptomatic patients.
Forced diuresis with oral hydration or oral administration of diuretics improves patient comfort and test applicability by shortening clinical waiting time and reducing the number of attempts to reach the sufficient urine volume for reliable measurements and can be applied safely for mild and moderately symptomatic patients. On the other hand, the risk of 25% of acute urinary retentions should be reconsidered, and the decision about diuretic stimuli should be made carefully by the clinician in severely symptomatic patients.
我们研究了口服补液或单剂量口服利尿剂强制利尿对下尿路症状患者尿流率参数和临床等待时间的影响。
本研究共纳入58例平均年龄59岁(范围41 - 77岁)的下尿路症状患者。根据国际前列腺症状评分将患者分为轻度、中度或重度症状组。使用经直肠超声计算患者的前列腺体积。连续3天进行尿流率测量。第1天,在无利尿剂刺激的情况下进行测试;第2天,进行口服补液;第3天,患者口服20毫克速尿。记录排尿时间、最大尿流率、排尿量以及排尿前经过的分钟数(等待时间)。
利尿剂刺激在各症状组中未显著改变尿流率参数,但等待时间显著缩短。强制利尿导致20例(25%)重度症状患者中有5例发生急性尿潴留。
口服补液或口服利尿剂进行强制利尿可通过缩短临床等待时间、减少为达到可靠测量所需足够尿量的尝试次数来提高患者舒适度和检查适用性,且可安全应用于轻度和中度症状患者。另一方面,应重新考虑25%的急性尿潴留风险,临床医生对重度症状患者应谨慎做出关于利尿剂刺激的决定。